Literature DB >> 15622962

Type 1 database mellitus: an inflammatory disease of the islet.

Regine Bergholdt1, Peter Heding, Karin Nielsen, Runa Nolsøe, Thomas Sparre, Joachim Størling, Jørn Nerup, Flemming Pociot, Thomas Mandrup-Poulsen.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15622962

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  7 in total

1.  Cytokine-mediated β-cell damage in PARP-1-deficient islets.

Authors:  Teresa Andreone; Gordon P Meares; Katherine J Hughes; Polly A Hansen; John A Corbett
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-04-24       Impact factor: 4.310

Review 2.  Novel biomarkers in type 1 diabetes.

Authors:  Yulan Jin; Jin-Xiong She
Journal:  Rev Diabet Stud       Date:  2012-12-28

3.  Dipeptidyl peptidase-4 activity might be a link between tumour necrosis factor alpha and insulin resistance in type 1 diabetes.

Authors:  Lea Duvnjak; Kristina Blaslov; Matea Nikolac Perković; Jadranka Knežević Ćuća
Journal:  Endocrine       Date:  2016-02-23       Impact factor: 3.633

4.  Schizandra arisanensis extract attenuates cytokine-mediated cytotoxicity in insulin-secreting cells.

Authors:  Yi-Shin Hsu; Yao-Haur Kuo; Hui-Ling Cheng; Peter R Flatt; Hui-Kang Liu
Journal:  World J Gastroenterol       Date:  2012-12-14       Impact factor: 5.742

5.  Lipoprotein-associated phospholipase A₂ activity predicts progression of subclinical coronary atherosclerosis.

Authors:  Gregory L Kinney; Janet K Snell-Bergeon; David M Maahs; Robert H Eckel; James Ehrlich; Marian Rewers; John E Hokanson
Journal:  Diabetes Technol Ther       Date:  2011-02-03       Impact factor: 6.118

6.  RNase L contributes to experimentally induced type 1 diabetes onset in mice.

Authors:  Chun Zeng; Xin Yi; Danny Zipris; Hongli Liu; Lin Zhang; Qiaoyun Zheng; Krishnamurthy Malathi; Ge Jin; Aimin Zhou
Journal:  J Endocrinol       Date:  2014-10-06       Impact factor: 4.286

Review 7.  Considerations for Defining Cytokine Dose, Duration, and Milieu That Are Appropriate for Modeling Chronic Low-Grade Inflammation in Type 2 Diabetes.

Authors:  Craig S Nunemaker
Journal:  J Diabetes Res       Date:  2016-10-23       Impact factor: 4.011
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.